Prazosin-induced	prazosin-induced	O	O
stress	stress	O	B_disease
incontinence	incontinence	O	I_disease
.	.	O	O

A	a	O	O
case	case	O	O
of	of	O	O
genuine	genuine	O	O
stress	stress	O	B_disease
incontinence	incontinence	O	I_disease
due	due	O	O
to	to	O	O
prazosin	prazosin	S_chemicals	O
,	,	O	O
a	a	O	O
common	common	O	O
antihypertensive	antihypertensive	B_chemicals	O
drug	drug	S_chemicals	O
,	,	O	O
is	is	O	O
presented	presented	O	O
.	.	O	O

Prazosin	prazosin	S_chemicals	O
exerts	exerts	O	O
its	its	O	O
antihypertensive	antihypertensive	S_chemicals	O
effects	effects	O	O
through	through	O	O
vasodilatation	vasodilatation	O	O
caused	caused	O	O
by	by	O	O
selective	selective	O	O
blockade	blockade	O	O
of	of	O	O
postsynaptic	postsynaptic	O	S_disease
alpha-1	alpha-1	B_chemicals	S_disease
adrenergic	adrenergic	B_chemicals	O
receptors	receptors	I_chemicals	O
.	.	O	O

As	as	O	O
an	an	O	O
alpha-blocker	alpha-blocker	O	O
,	,	O	O
it	it	O	O
also	also	O	O
exerts	exerts	O	O
a	a	O	O
significant	significant	O	O
relaxant	relaxant	O	O
effect	effect	O	O
on	on	O	O
the	the	O	O
bladder	bladder	O	O
neck	neck	O	O
and	and	O	O
urethra	urethra	O	O
.	.	O	O

The	the	O	O
patient	patient	O	O
's	's	O	O
clinical	clinical	O	B_disease
course	course	O	I_disease
is	is	O	O
described	described	O	O
and	and	O	O
correlated	correlated	O	O
with	with	O	O
initial	initial	O	O
urodynamic	urodynamic	O	O
studies	studies	O	O
while	while	O	O
on	on	O	O
prazosin	prazosin	S_chemicals	O
and	and	O	O
subsequent	subsequent	O	O
studies	studies	O	O
while	while	O	O
taking	taking	O	O
verapamil	verapamil	S_chemicals	O
.	.	O	O

Her	her	S_chemicals	O
incontinence	incontinence	O	O
resolved	resolved	O	O
with	with	O	O
the	the	O	O
change	change	O	O
of	of	O	O
medication	medication	O	O
.	.	O	O

The	the	O	O
restoration	restoration	O	O
of	of	O	O
continence	continence	O	O
was	was	O	O
accompanied	accompanied	O	O
by	by	O	O
a	a	O	O
substantial	substantial	O	O
rise	rise	O	O
in	in	O	O
maximum	maximum	O	O
urethral	urethral	O	O
pressure	pressure	O	O
,	,	O	O
maximum	maximum	O	O
urethral	urethral	O	O
closure	closure	O	O
pressure	pressure	O	O
,	,	O	O
and	and	O	O
functional	functional	O	O
urethral	urethral	O	O
length	length	O	O
.	.	O	O

Patients	patients	O	O
who	who	O	O
present	present	O	O
with	with	O	O
stress	stress	O	B_disease
incontinence	incontinence	O	I_disease
while	while	O	O
taking	taking	O	O
prazosin	prazosin	S_chemicals	O
should	should	O	O
change	change	O	O
their	their	O	O
antihypertensive	antihypertensive	S_chemicals	O
medication	medication	O	O
before	before	O	O
considering	considering	O	O
surgery	surgery	O	O
,	,	O	O
because	because	O	O
their	their	O	O
incontinence	incontinence	O	O
may	may	O	O
resolve	resolve	O	O
spontaneously	spontaneously	O	O
with	with	O	O
a	a	O	O
change	change	O	O
in	in	O	O
drug	drug	S_chemicals	O
therapy	therapy	O	O
.	.	O	O

